Lin P.-Y.SUNG-LIANG YUPAN-CHYR YANG2020-06-172020-06-1720100007-0920https://scholars.lib.ntu.edu.tw/handle/123456789/502904MicroRNAs (miRNAs) are small non-protein-coding RNAs that function as endogenous negative gene regulators. Dysfunctions of miRNAs are frequently found in malignancies, including lung cancer. In this review, we summarise the current understanding of miRNAs in lung cancer tumourigenesis, and highlight their potential in overcoming drug resistance, abetting histological sub-classification techniques, and serving as biomarkers for lung cancer risk stratification and outcome prediction. ? 2010 Cancer Research UK.[SDGs]SDG3biological marker; microRNA; antineoplastic agent; microRNA; cancer risk; gene control; lung cancer; lung carcinogenesis; outcome assessment; priority journal; risk assessment; short survey; animal; biological model; biosynthesis; Carcinoma, Non-Small-Cell Lung; drug delivery system; genetics; human; Lung Neoplasms; pathology; physiology; procedures; prognosis; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Delivery Systems; Humans; Lung Neoplasms; MicroRNAs; Models, Biological; Prognosis; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Delivery Systems; Humans; Lung Neoplasms; MicroRNAs; Models, Biological; Prognosisjournal article10.1038/sj.bjc.6605901208592902-s2.0-77957982985